Key Points Home Depot stock is down 25% from its previous peak, bringing its forward dividend yield to 2.7%. PepsiCo shares are down 22%, and it's currently offering a 3.7% forward yield. 10 stocks we like better than Home Depot › The stock market makes it possible for anyone to build wealth, but the occasional dip is simply the price we pay for long-term returns. That's where dividend stocks can ...
Key Points Home Depot stock is down 25% from its previous peak, bringing its forward dividend yield to 2.7%. PepsiCo shares are down 22%, and it's currently offering a 3.7% forward yield. 10 stocks we like better than Home Depot › The stock market makes it possible for anyone to build wealth, but the occasional dip is simply the price we pay for long-term returns. That's where dividend stocks can help. Even in a brutal bear market, rock-solid companies can keep sending cash to your account, making it a lot easier to stay the course. For income-focused investors, here are two S&P 500 blue chips with long dividend-growth records -- and yields that look attractive today. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » 1. Home Depot Home Depot (NYSE: HD) is the world's largest home improvement retailer, serving a $1 trillion addressable market. Yet the stock is currently down 25% from its prior peak as the housing market has cooled. A dividend stock's yield can offer a quick read on value. Home Depot has paid a quarterly dividend for more than 35 years. It recently raised its quarterly dividend by 1.3%, bringing the annual payout to $9.32 per share. That puts the forward yield at an attractive 2.85% -- more than double the S&P 500 average. Sales growth has been sluggish. Comparable sales in the fourth quarter rose just 0.4% year over year. Inflation and higher interest rates have pressured demand, but these headwinds tend to come and go in cycles. Management is still playing the long game. It's opening more stores and leveraging a large footprint of valuable real estate -- a key advantage as more customers order online and pick up in-store. Digital sales climbed 11% year over year last quarter. The dividend has grown about 9% annually over the past five years. With $164 billion in trailing revenue and...
Eli Lilly (LLY 1.18%) has climbed in recent years as growth investors piled into the stock. Generally, big pharmaceutical companies aren't known for delivering enormous levels of growth and instead may gain at a more measured pace. Lilly has stood out, however, thanks to one product portfolio in particular: its weight loss drug portfolio. This pharma powerhouse sells tirzepatide, marketed under th...
Eli Lilly (LLY 1.18%) has climbed in recent years as growth investors piled into the stock. Generally, big pharmaceutical companies aren't known for delivering enormous levels of growth and instead may gain at a more measured pace. Lilly has stood out, however, thanks to one product portfolio in particular: its weight loss drug portfolio. This pharma powerhouse sells tirzepatide, marketed under the name Mounjaro for type 2 diabetes and as Zepbound for obesity, and it's been bringing in blockbuster revenue. Demand has been high, even surpassing supply at certain points, as tirzepatide and rival semaglutide, sold by Novo Nordisk, have proven their ability to help people lose weight safely over a period of months. Lilly stock has dipped this year, but over the past three, it's climbed more than 100%. And now, a new catalyst may be right around the corner -- on April 10. Should you buy Lilly stock before that date? Let's find out. Mounjaro and Zepbound First, let's dive a bit deeper into Lilly's weight loss drug story. Tirzepatide first entered the market as Mounjaro, which doctors have prescribed off-label for weight loss, in 2022. More recently, the drug won regulatory approval specifically for weight loss under the name Zepbound. Tirzepatide is part of the GLP-1 class of drugs, interacting with hormonal pathways involved in the digestion process. It helps control appetite and blood sugar levels, helping patients shed pounds. In the latest quarter, Mounjaro and Zepbound each delivered triple-digit revenue growth, and together, they brought in more than $11 billion for Lilly. Before we get to the catalyst ahead, it's important to note that these drugs are available in an injection pen or in a vial that requires a syringe, and patients must give themselves an injection weekly. Now, the catalyst: Lilly has submitted orforglipron, its oral weight loss candidate, to the U.S. Food and Drug Administration, and regulators are expected to issue a decision very soon. In fact, R...
There has been a move out of large-cap growth stocks into other asset classes, and one of the major beneficiaries has been mid caps. Mid-cap stocks are generally not as expensive as large caps and are viewed as more stable than small caps, giving them a better growth profile than both, particularly as interest rates are expected to decline. So far this year, the S&P 400 mid-cap index is up about 1...
There has been a move out of large-cap growth stocks into other asset classes, and one of the major beneficiaries has been mid caps. Mid-cap stocks are generally not as expensive as large caps and are viewed as more stable than small caps, giving them a better growth profile than both, particularly as interest rates are expected to decline. So far this year, the S&P 400 mid-cap index is up about 1%, while the S&P 500 (^GSPC 1.51%) is down about 4% and the Russell 2000 is little changed (as of March 19). Another area that is seeing investor interest is dividend stocks. The Dow Jones US Dividend 100 Index, which includes large- and mid-cap dividend stocks, is up about 10% in 2026, topping the major indexes. With mounting doubts about the long-term performance of large-cap stocks this year, and perhaps beyond, mid-cap and dividend stocks could be two sweet spots for the markets right now. Here are two excellent mid-cap dividend stocks for investors looking to switch out of large caps. 1. Main Street Capital Main Street Capital (MAIN 0.69%) is a top-quality dividend stock that delivers high-yield passive income monthly. It's a business development company, or BDC, which is required by law to distribute 90% of its income in dividends in exchange for certain tax breaks. As a BDC, Main Street Capital provides funding and loans as well as debt services for smaller companies with annual revenue up to about $500 million. Currently, it has an investment portfolio of roughly 200 companies. Expand NYSE : MAIN Main Street Capital Today's Change ( -0.69 %) $ -0.38 Current Price $ 55.01 Key Data Points Market Cap $5.0B Day's Range $ 54.31 - $ 55.65 52wk Range $ 46.07 - $ 66.76 Volume 3.1M Avg Vol 692K Gross Margin 100.00 % Dividend Yield 6.57 % It is one of a relatively few companies that pays out a monthly dividend -- so investors get 12 payouts per year. It is a fantastic dividend stock with a yield of 5.7%, which is almost five times higher than the S&P 500 average dividend. It ...
Key Points Eli Lilly dominates the U.S. weight loss drug market. The company’s weight loss portfolio brought in more than $11 billion in the latest quarter. 10 stocks we like better than Eli Lilly › Eli Lilly (NYSE: LLY) has climbed in recent years as growth investors piled into the stock. Generally, big pharmaceutical companies aren't known for delivering enormous levels of growth and instead may...
Key Points Eli Lilly dominates the U.S. weight loss drug market. The company’s weight loss portfolio brought in more than $11 billion in the latest quarter. 10 stocks we like better than Eli Lilly › Eli Lilly (NYSE: LLY) has climbed in recent years as growth investors piled into the stock. Generally, big pharmaceutical companies aren't known for delivering enormous levels of growth and instead may gain at a more measured pace. Lilly has stood out, however, thanks to one product portfolio in particular: its weight loss drug portfolio. This pharma powerhouse sells tirzepatide, marketed under the name Mounjaro for type 2 diabetes and as Zepbound for obesity, and it's been bringing in blockbuster revenue. Demand has been high, even surpassing supply at certain points, as tirzepatide and rival semaglutide, sold by Novo Nordisk, have proven their ability to help people lose weight safely over a period of months. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Lilly stock has dipped this year, but over the past three, it's climbed more than 100%. And now, a new catalyst may be right around the corner -- on April 10. Should you buy Lilly stock before that date? Let's find out. Mounjaro and Zepbound First, let's dive a bit deeper into Lilly's weight loss drug story. Tirzepatide first entered the market as Mounjaro, which doctors have prescribed off-label for weight loss, in 2022. More recently, the drug won regulatory approval specifically for weight loss under the name Zepbound. Tirzepatide is part of the GLP-1 class of drugs, interacting with hormonal pathways involved in the digestion process. It helps control appetite and blood sugar levels, helping patients shed pounds. In the latest quarter, Mounjaro and Zepbound each delivered triple-digit revenue growth, and together, they brought in more than $11 ...
Amazon is investing $4 billion to push two-day delivery further across its network—and finding it takes a lot to get packages to the wilds of Montana within 48 hours.
Amazon is investing $4 billion to push two-day delivery further across its network—and finding it takes a lot to get packages to the wilds of Montana within 48 hours.
A University of Kent student, who had returned home following the outbreak, said he got up at 04:00 GMT on Friday to drive from Ipswich with his mum to get the vaccine.
A University of Kent student, who had returned home following the outbreak, said he got up at 04:00 GMT on Friday to drive from Ipswich with his mum to get the vaccine.
Polls opened on Sunday in Slovenia’s election pitting incumbent liberal Prime Minister Robert Golob against right-wing populist Janez Janša, with victory and a parliamentary majority out of reach for both in a vote that could be decided by smaller coalition partners. Nearly 1.7 million Slovenians will be able to cast votes at polling stations that opened at 7am across the Alpine country and will ...
Polls opened on Sunday in Slovenia’s election pitting incumbent liberal Prime Minister Robert Golob against right-wing populist Janez Janša, with victory and a parliamentary majority out of reach for both in a vote that could be decided by smaller coalition partners. Nearly 1.7 million Slovenians will be able to cast votes at polling stations that opened at 7am across the Alpine country and will close at 7pm. The election commission is expected to announce the preliminary results after 8.30pm. The latest opinion polls indicated Jansa’s pro-Trump Slovenian Democratic Party (SDS) and Golob’s Freedom Movement (GS) were set for a close race after eleventh-hour campaign drama involving allegations of foreign meddling and corruption. Advertisement Jansa said the vote is one of the most important in Slovenia’s 35 years of independence, and will decide the future direction of the country. “I hope that Slovenia will get rid of the organised criminal organisation,” he told reporters after casting his vote in the village of Arnace, 85 km northwest of the capital Ljubljana. Advertisement Analysts say Jansa, who previously served as prime minister three times in the European Union and Nato member state of 2 million people, has a devoted voter base and the lower the turnout, the higher the chances of him winning the election.
Key Points SpaceX quietly raised prices on its Falcon 9 launches -- and its Transporter ride-share launches as well. The company continues to underprice everyone else in the industry. But now it's going to be even more profitable -- just in time for its IPO. 10 stocks we like better than Lockheed Martin › "Never let a good crisis go to waste." The phrase has been alternately attributed to everyone...
Key Points SpaceX quietly raised prices on its Falcon 9 launches -- and its Transporter ride-share launches as well. The company continues to underprice everyone else in the industry. But now it's going to be even more profitable -- just in time for its IPO. 10 stocks we like better than Lockheed Martin › "Never let a good crisis go to waste." The phrase has been alternately attributed to everyone from Niccolo Machiavelli in 1513 to Winston Churchill in 1945 to... Rahm Emmanuel in 2008. But in 2026, it's Elon Musk who's putting the principle into practice at SpaceX. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Things are not going well for Musk's rivals over at Boeing (NYSE: BA) and Lockheed Martin's (NYSE: LMT) joint venture, United Launch Alliance, you see. ULA has a new rocket, the Vulcan Centaur, that it hopes will replace its outgoing Atlas V. The problem is, Vulcan's only been able to launch four times in the past two years -- and during two of those launches, parts started falling off midflight! Last month, the U.S. Space Force ordered Vulcan launches halted while ULA figures out a fix to its disintegrating-rockets problem, leaving the U.S. government with just one space company remaining with which to launch its satellites: SpaceX. And how is SpaceX responding? Is it cheering ULA along and waiting patiently for its rival to right the ship and resume Vulcan launches so the two companies can compete on a level playing field? No, it is not. Instead, SpaceX is raising its prices on Falcon 9 launches... just months ahead of an expected $1.75 trillion IPO. SpaceX raises prices -- again When SpaceX first began commercial launches of its new Falcon 9 rocket, its advertised price -- $61.2 million -- was the lowest in America and just a fraction of the $350 million and up that ULA was charging at...
Key Points Broadcom has a huge opportunity in front of it with custom AI chips. Amazon is both an e-commerce and cloud computing leader. 10 stocks we like better than Broadcom › The stock market has been volatile lately as war rages on in the Middle East and earnings season winds down. If you're looking to dip your toe into some stocks, say with $1,000, let's look at two strong options. Will AI cr...
Key Points Broadcom has a huge opportunity in front of it with custom AI chips. Amazon is both an e-commerce and cloud computing leader. 10 stocks we like better than Broadcom › The stock market has been volatile lately as war rages on in the Middle East and earnings season winds down. If you're looking to dip your toe into some stocks, say with $1,000, let's look at two strong options. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Broadcom Broadcom (NASDAQ: AVGO) has struggled to find its footing a bit in the market this year, but the company has one of the best growth outlooks in the megacap tech space. The company is seeing strong momentum in its data center networking business, but its biggest opportunity is in custom AI chips. As spending on AI infrastructure continues to climb, hyperscalers (owners of large data centers) are increasingly looking for cheaper alternatives to Nvidia's graphics processing units (GPUs). One of the best options is to develop custom chips called ASICs (application-specific integrated circuits), which are hardwired chips designed for specific tasks. Broadcom has proven itself a leader in this field, helping co-develop Alphabet's highly successful tensor processing units (TPUs). With TPU demand soaring and Broadcom securing commitments from other hyperscalers to help them create their own custom AI ASICs, Broadcom is set to see explosive growth. The company said it is on track to generate more than $100 billion in AI ASIC revenue alone in its fiscal 2027, which is more than 1.5 times its total fiscal 2025 revenue. Given its huge growth opportunity ahead and the market tailwinds shifting in its favor, now is a great time to scoop up Broadcom shares. Amazon Amazon (NASDAQ: AMZN) is another stock that has lagged to start the year. While higher fuel prices are a headwi...
As Warren Buffett hands over the reins of conglomerate Berkshire Hathaway (BRKA 0.29%) (BRKB +0.11%), questions abound about who will really manage the company's $308 billion equity portfolio and deploy its $373 billion in cash and short-term Treasury bills. Over a decade ago, Buffett hired Todd Combs and Ted Weschler, both former hedge fund managers, and tasked them with managing a small portion ...
As Warren Buffett hands over the reins of conglomerate Berkshire Hathaway (BRKA 0.29%) (BRKB +0.11%), questions abound about who will really manage the company's $308 billion equity portfolio and deploy its $373 billion in cash and short-term Treasury bills. Over a decade ago, Buffett hired Todd Combs and Ted Weschler, both former hedge fund managers, and tasked them with managing a small portion of Berkshire's overall stock portfolio. After Buffett announced his retirement and Combs departed Berkshire late last year, I had thought Weschler would run the bulk of Berkshire's public stock investments going forward. However, new CEO Greg Abel's first letter to shareholders seemed to indicate something quite different. Expand NYSE : BRKB Berkshire Hathaway Today's Change ( 0.11 %) $ 0.55 Current Price $ 482.03 Key Data Points Market Cap $1.0T Day's Range $ 479.75 - $ 485.10 52wk Range $ 455.19 - $ 542.07 Volume 230K Avg Vol 4.8M Gross Margin 23.63 % Abel to wear all the hats? In his first letter to shareholders, Greg Abel went through Berkshire's businesses in great detail -- actually, much more detail than Buffett himself usually did. Abel came up through Berkshire via MidAmerican Energy, Berkshire's energy and utility operation, so it was not a surprise to hear him go through Berkshire's owned operations so thoroughly. But when Buffett handed over the CEO job to Abel, many, yours truly included, believed Abel would run the operating businesses at Berkshire, while Weschler would manage the stock portfolio. However, that doesn't appear to be the case. In Abel's letter, he writes: At Berkshire, equity investments are fundamental to our capital allocation activities; responsibility ultimately resides with me as CEO. Ted Weschler manages about 6% of our investments, including a portion of the portfolio formerly overseen by Todd Combs. Ted's impact extends beyond these investments, as he continues to play a broader role in assessing significant opportunities, providing valu...
Key Points With Buffett retiring and Todd Combs leaving the company, I had thought Ted Weschler would manage Berkshire's massive stock holdings. However, it appears most of the responsibility will fall to new CEO Greg Abel. Here are the potential consequences of Abel's elevated role for Berkshire shareholders. 10 stocks we like better than Berkshire Hathaway › As Warren Buffett hands over the rein...
Key Points With Buffett retiring and Todd Combs leaving the company, I had thought Ted Weschler would manage Berkshire's massive stock holdings. However, it appears most of the responsibility will fall to new CEO Greg Abel. Here are the potential consequences of Abel's elevated role for Berkshire shareholders. 10 stocks we like better than Berkshire Hathaway › As Warren Buffett hands over the reins of conglomerate Berkshire Hathaway (NYSE: BRKA) (NYSE: BRKB), questions abound about who will really manage the company's $308 billion equity portfolio and deploy its $373 billion in cash and short-term Treasury bills. Over a decade ago, Buffett hired Todd Combs and Ted Weschler, both former hedge fund managers, and tasked them with managing a small portion of Berkshire's overall stock portfolio. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » After Buffett announced his retirement and Combs departed Berkshire late last year, I had thought Weschler would run the bulk of Berkshire's public stock investments going forward. However, new CEO Greg Abel's first letter to shareholders seemed to indicate something quite different. Abel to wear all the hats? In his first letter to shareholders, Greg Abel went through Berkshire's businesses in great detail -- actually, much more detail than Buffett himself usually did. Abel came up through Berkshire via MidAmerican Energy, Berkshire's energy and utility operation, so it was not a surprise to hear him go through Berkshire's owned operations so thoroughly. But when Buffett handed over the CEO job to Abel, many, yours truly included, believed Abel would run the operating businesses at Berkshire, while Weschler would manage the stock portfolio. However, that doesn't appear to be the case. In Abel's letter, he writes: At Berkshire, equity investments are fundamental t...
Beau Greaves' record 114-match winning streak in the PDC Women's Series came to an end as she lost to 4-1 to Fallon Sherrock in Wigan on Saturday. Three-time women's world champion Greaves, the first woman to hit a nine-dart finish on the PDC ProTour, had not been beaten since April 2025 and had won 17 women's events in a row. Sherrock, who averaged 102.12 to the 100.28 produced by Greaves, went o...
Beau Greaves' record 114-match winning streak in the PDC Women's Series came to an end as she lost to 4-1 to Fallon Sherrock in Wigan on Saturday. Three-time women's world champion Greaves, the first woman to hit a nine-dart finish on the PDC ProTour, had not been beaten since April 2025 and had won 17 women's events in a row. Sherrock, who averaged 102.12 to the 100.28 produced by Greaves, went on to lose 5-3 to Lisa Ashton in the final of the fifth event of the PDC Women's Series. Greaves bounced back to win the sixth round, which took place on Saturday night, beating Gemma Hayter 5-0 in the final to secure her fifth title of the year.